Phase 2 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 79 years
- People who have had a specific type of heart attack called an anterior wall STEMI (a blockage affecting the front wall of the heart)
- People who have undergone an emergency procedure to open a blocked heart artery (known as a primary PCI, done via a coronary angiogram)
Who may not be able to join:
- People who have had a previous heart attack, a heart artery procedure (PCI), or open-heart bypass surgery within the past year
- People with a known history of reduced heart pumping function (the heart pumping less than 40% of its capacity)
- People who have used an experimental drug or medical device in the 30 days before joining the trial
- People with a known allergy or medical reason to avoid gadolinium or contrast dye (substances used in certain scans)
- People with significantly reduced kidney function (confirm with trial site)
- People who have any reason they cannot safely have a cardiac MRI scan, such as having certain metal implants in their body
- Women who are pregnant or breastfeeding; women who could become pregnant must have a negative pregnancy test before joining
- People who weigh more than 140 kg (approximately 309 lbs)
- People with a low level of a specific type of white blood cell called neutrophils (confirm with trial site)
- People with a history of chronic liver disease
- People with significantly elevated liver enzyme levels (both ALT and AST raised to more than twice the normal upper limit)
- People who have an iron storage condition such as hemochromatosis or thalassemia, or who are already taking medication to remove excess iron from the body
- People with any other significant health concern that, in the trial doctor's judgment, could make it unsafe to participate or could affect the trial results
- People whose life expectancy is less than one year due to a non-heart-related illness
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Keyur P Vora, MD FACP FACC, Medical Imaging Research Institute, Indiana University School of Medicine
Phone: (317) 274-0985
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment Efficacy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.